Kamiya Biomedical Company, LLC

Kamiya Biomedical Company, LLC — FDA 510(k) Submissions

Kamiya Biomedical Company, LLC has submitted 1 FDA 510(k) premarket notifications since 2025, of which 1 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include C-reactive Protein, Antigen, Antiserum, And Control . Use the specialty filter in the sidebar to narrow results.